![Thomas Burns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Burns
Vorstandsvorsitzender bei
GLAUKOS CORPORATION
Vermögen: 183 Mio $ am 31.05.2026
Profil
Thomas William Burns was the founder of DOSE Medical Corp., founded in 2009, where the title held was Chairman from 2015 to 2019.
Current jobs include Chairman & Chief Executive Officer at Glaukos Corp.
since 2022, and Independent Director at Pulmonx Corp.
since 2020.
Former jobs include President, Chief Operating Officer & Director at Oldtech, Inc.; Independent Director at Avedro, Inc. from 2018 to 2019; VP-Global Strategy & GM-Refractive Surgery at Bausch & Lomb, Inc. from 1998 to 2000; Entrepreneur-in-Residence at Versant Venture Management LLC; and Senior Vice President & General Manager at Chiron Vision Corp.
from 1990 to 1997.
Education includes undergraduate studies at Yale University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLAUKOS CORP 3,09 % | 02.04.2026 | 1.772.726 ( 3,09 % ) | 183 Mio $ | 31.05.2026 |
PULMONX CORP. 0,27 % | 05.06.2026 | 113.399 ( 0,27 % ) | 187 108 $ | 31.05.2026 |
Aktive Positionen von Thomas Burns
| Unternehmen | Position | Beginn |
|---|---|---|
| GLAUKOS CORPORATION | Vorstandsvorsitzender | 01.01.2001 |
| PULMONX CORPORATION | Direktor/Vorstandsmitglied | 01.09.2020 |
Ehemalige bekannte Positionen von Thomas Burns
| Unternehmen | Position | Ende |
|---|---|---|
| AVEDRO, INC. | Direktor/Vorstandsmitglied | 06.08.2019 |
DOSE Medical Corp.
 DOSE Medical Corp. Medical DistributorsDistribution Services Develops multiple micro-invasive, bioerodible, sustained-release drug delivery platforms | Vorstandsvorsitzender | 01.06.2015 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Corporate Officer/Principal | 01.01.2000 |
Chiron Vision Corp. | Corporate Officer/Principal | 01.01.1997 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Corporate Officer/Principal | - |
Ausbildung von Thomas Burns
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Pulmonx Corp.
 Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
DOSE Medical Corp.
DOSE Medical Corp. Medical DistributorsDistribution Services Develops multiple micro-invasive, bioerodible, sustained-release drug delivery platforms | Distribution Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Chiron Vision Corp. |
